{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T17:09:46Z","timestamp":1771607386526,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.abd.2025.501266","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:09:13Z","timestamp":1767773353000},"page":"501266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The morbidity of systemic steroids: analyzing its use in bullous pemphigoid"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7609-2736","authenticated-orcid":false,"given":"Lula Mar\u00eda","family":"Nieto-Benito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Su\u00e1rez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2025.501266_bib0005","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/jdv.18220","article-title":"Updated S2K guidelines for the management of bullous pemphigoid initiated by the european academy of dermatology and venereology (EADV)","volume":"36","author":"Borradori","year":"2022","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2025.501266_bib0010","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s40257-020-00513-3","article-title":"A review comparing international guidelines for the management of bullous pemphigoid, pemphigoid gestationis, mucous membrane pemphigoid and epidermolysis bullosa acquisita","volume":"21","author":"Patel","year":"2020","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.abd.2025.501266_bib0015","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/bjd.20593","article-title":"International multicentre observational study to assess the efficacy and safety of 0.5 mg kg\u22121 per day starting dose of oral corticosteroids to treat bullous pemphigoid","volume":"185","author":"H\u00e9bert","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2025.501266_bib0020","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/1346-8138.15816","article-title":"Clinical characteristics and outcomes of bullous pemphigoid patients with versus without oral prednisolone treatment","volume":"48","author":"Ujiie","year":"2021","journal-title":"J Dermatol."},{"key":"10.1016\/j.abd.2025.501266_bib0025","first-page":"55","article-title":"Mortality of patients with bullous pemphigoid in Italy: a retrospective study of a monocentric experience","volume":"157","author":"Chessa","year":"2022","journal-title":"Ital J Dermatol Venerol."},{"key":"10.1016\/j.abd.2025.501266_bib0030","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/bjd\/ljae219","article-title":"Risk of death, major adverse cardiac events and relapse in patients with bullous pemphigoid treated with systemic or topical corticosteroids","volume":"191","author":"Kridin","year":"2024","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2025.501266_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1176284","article-title":"Effect of early initiation of steroid-sparing drugs in patients with bullous pemphigoid","volume":"14","author":"Fenne","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.abd.2025.501266_bib0040","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1111\/jdv.18441","article-title":"Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study","volume":"36","author":"Bardazzi","year":"2022","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2025.501266_bib0045","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1111\/jdv.16363","article-title":"AntiBP-180 autoantibody levels at diagnosis correlate with 1-year mortality rates in patients with bullous pemphigoid","volume":"34","author":"Monshi","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2025.501266_bib0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.abd.2024.04.012","article-title":"Dupilumab, corticosteroids and their combination for the treatment of bullous pemphigoid","volume":"100","author":"Liang","year":"2025","journal-title":"An Bras Dermatol."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059625002089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059625002089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:18:50Z","timestamp":1771604330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059625002089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0365059625002089"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2025.501266","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The morbidity of systemic steroids: analyzing its use in bullous pemphigoid","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2025.501266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501266"}}